BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7814852)

  • 1. Comparison of calcium, magnesium-ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls.
    Miller MA; Sagnella GA; Markandu ND; MacGregor GA
    J Hypertens; 1994 Aug; 12(8):929-38. PubMed ID: 7814852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte calcium-stimulated, magnesium-activated adenosine 5'-triphosphatase activity in essential hypertension.
    Adeoya AS; Bing RF; Norman RI
    J Hypertens; 1992 Jul; 10(7):651-6. PubMed ID: 1321192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
    Carr SJ; Sikand K; Moore D; Norman RI
    J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in essential hypertension.
    Caimi G
    Clin Hemorheol Microcirc; 1997; 17(3):199-208. PubMed ID: 9356784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane fluidity and Na+/K+ ATPase activity in acute stroke.
    Nanetti L; Vignini A; Raffaelli F; Moroni C; Silvestrini M; Provinciali L; Mazzanti L
    Brain Res; 2008 Apr; 1205():21-6. PubMed ID: 18343354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
    Fu Y; Wang S; Lu Z; Li H; Li S
    Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet membrane Ca(2+)-ATPase: blunted calmodulin-stimulation in essential hypertension.
    Resink TJ; Tkachuk VA; Erne P; Bühler FR
    J Hypertens Suppl; 1985 Dec; 3(3):S37-40. PubMed ID: 2856741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The (Ca2+, Mg2+)-ATPase activity in erythrocyte membranes from essential hypertensive patients.
    Gutiérrez A; Ariza R; Frati-Munari AC; Oliva G; Mas-Oliva J
    Arch Invest Med (Mex); 1991; 22(3-4):279-83. PubMed ID: 1844113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane fluidity as a genetic marker of hypertension.
    Tsuda K; Ueno Y; Nishio I; Masuyama Y
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():11-6. PubMed ID: 1446403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension.
    Caimi G; Lo Presti R; Montana M; Contorno A; Canino B; Catania A; Sarno A; Cerasola G
    Am J Hypertens; 1995 Jan; 8(1):82-6. PubMed ID: 7734103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous Na+, K(+)-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension.
    Tsuda K; Shima H; Takeda J; Kimura K; Nishio I; Masuyama Y
    J Hypertens; 1992 Jul; 10(7):657-61. PubMed ID: 1321193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White-coat hypertension and sex.
    James GD; Marion R; Pickering TG
    Blood Press Monit; 1998 Oct; 3(5):281-287. PubMed ID: 10212367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further investigation of platelet cytosolic alkalinization in essential hypertension.
    Astarie C; Le Quan Sang KH; David-Dufilho M; Devynck MA
    J Hypertens; 1992 Aug; 10(8):849-54. PubMed ID: 1325518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipids and platelet membrane fluidity in essential hypertension.
    Le Quan Sang KH; Mazeaud M; Astarie C; Duranthon V; Driss F; Devynck MA
    Thromb Haemost; 1993 Jan; 69(1):70-6. PubMed ID: 8383361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered levels of erythrocyte calcium-binding proteins in essential hypertensives with genetic predisposition: correlation with ambulatory blood pressure.
    Hojo Y; Ebata H; Kawasaki K; Tsuruya Y; Ikeda U; Nishinaga M; Natsume T; Ishida H; Shimada K
    J Hypertens; 1994 Apr; 12(4):429-37. PubMed ID: 8064167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered calcium binding to erythrocyte membranes in essential hypertension: relation to magnesium.
    Touyz RM; Milne FJ; Reinach SG
    J Hum Hypertens; 1993 Feb; 7(1):59-64. PubMed ID: 8450522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between insulin resistance and abnormalities of cellular calcium metabolism and cell membrane abnormalities in patients with essential hypertension].
    Fu Y; Wang S; Lu Z
    Zhonghua Yi Xue Za Zhi; 1997 Jun; 77(6):443-6. PubMed ID: 9772510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular responses to exercise in essential hypertension.
    Balogun MO; Ladipo GO
    West Afr J Med; 1990; 9(4):272-8. PubMed ID: 2083204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between lipoproteins and platelet membranes in obesity.
    Raffaelli F; Nanetti L; D'Angelo M; Montecchiani G; Alidori A; Montesi L; Faloia E; Vignini A; Mazzanti L
    Obesity (Silver Spring); 2009 Jul; 17(7):1375-80. PubMed ID: 19197263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential hypertension: leukocyte rheology and polymorphonuclear cytosolic Ca2+ content at baseline and after activation.
    Caimi G; Lo Presti R; Canino B; Montana M; Ferrara L; Oddo G; Ventimiglia G; Cerasola G
    Clin Hemorheol Microcirc; 1998 Dec; 19(4):281-9. PubMed ID: 9972665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.